Nuveen’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.09M Buy
240,817
+8,085
+3% +$103K ﹤0.01% 2095
2025
Q4
$2.09M Hold
232,732
﹤0.01% 2274
2025
Q3
$4.02M Sell
232,732
-4,709
-2% -$58K ﹤0.01% 2008
2025
Q2
$2.23M Sell
237,441
-34,856
-13% -$286K ﹤0.01% 2254
2025
Q1
$1.94M Buy
272,297
+11,600
+4% +$117K ﹤0.01% 2348
2024
Q4
$3.04M Sell
260,697
-105,170
-29% -$1.64M ﹤0.01% 2211
2024
Q3
$7.52M Sell
365,867
-499,764
-58% -$11.5M ﹤0.01% 1779
2024
Q2
$19.4M Buy
865,631
+481,763
+126% +$11.5M 0.01% 1154
2024
Q1
$10.6M Sell
383,868
-91,880
-19% -$2.55M ﹤0.01% 1552
2023
Q4
$14.5M Sell
475,748
-32,812
-6% -$943K ﹤0.01% 1354
2023
Q3
$16.1M Buy
508,560
+7,332
+1% +$284K 0.01% 1172
2023
Q2
$20.4M Sell
501,228
-556,990
-53% -$22.6M 0.01% 1049
2023
Q1
$39.4M Buy
1,058,218
+394,012
+59% +$15.5M 0.01% 659
2022
Q4
$23.2M Buy
664,206
+272,982
+70% +$13M 0.01% 938
2022
Q3
$21.9M Sell
391,224
-32,690
-8% -$2.03M 0.01% 950
2022
Q2
$21.9M Buy
423,914
+84,420
+25% +$4.29M 0.01% 991
2022
Q1
$23.8M Sell
339,494
-15,014
-4% -$1.27M 0.01% 1080
2021
Q4
$41.9M Sell
354,508
-31,272
-8% -$3.92M 0.01% 775
2021
Q3
$51.8M Sell
385,780
-56,977
-13% -$8.63M 0.02% 670
2021
Q2
$71.7M Sell
442,757
-111,200
-20% -$8.66M 0.02% 592
2021
Q1
$44.5M Buy
553,957
+44,722
+9% +$3M 0.01% 789
2020
Q4
$27.7M Buy
509,235
+50,035
+11% +$1.82M 0.01% 1034
2020
Q3
$9.13M Buy
459,200
+17,917
+4% +$374K ﹤0.01% 1578
2020
Q2
$9.28M Buy
441,283
+144,568
+49% +$2.46M ﹤0.01% 1526
2020
Q1
$3.63M Sell
296,715
-302,688
-50% -$4.08M ﹤0.01% 1888
2019
Q4
$8.79M Buy
599,403
+451,102
+304% +$6.28M ﹤0.01% 1662
2019
Q3
$1.98M Buy
148,301
+716
+0.5% +$11.4K ﹤0.01% 2406
2019
Q2
$2.42M Buy
+147,585
New +$2.32M ﹤0.01% 2345

Other funds holding NTLA